Navigation Links
InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
Date:12/4/2012

ntees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multi-national companies, (v) product liability claims, (vi) our limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) our reliance on single suppliers for certain product components, (xi) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), includ
'/>"/>
SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
9. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
10. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
11. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 A six-hour certification ... is being presented at the Cannabis World Congress & ... New York, NY .  Taking place on Wednesday, ... dedicated day of education at the leading event on the ... Led by Clover Leaf University, the first cannabis ...
(Date:5/29/2015)... May 28, 2015 Research and Markets ( ... "North America Open System MRI Market - Growth, Trends ... offering. The key players in the industry ... Siemens Healthcare and Toshiba Medical Systems ... replacing CT because of its higher sensitivity and use ...
(Date:5/29/2015)... , May 29, 2015 Eli Lilly ... Goldman Sachs 36th Annual Global Healthcare Conference on Tuesday, ... president and president, Elanco Animal Health, will participate in ... A live audio webcast will be ... investor website at http://investor.lilly.com/events.cfm . A replay of ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2Lilly to Participate in Goldman Sachs Global Healthcare Conference 2
... AutoGenomics, a leader in,developing automated molecular testing solutions, ... submitted to the FDA for 510(k) clearance,late last ... Medical,School-Partners HealthCare Center for Genetics and Genomics (HPCGG). ... prescribed to help prevent,blood clots. With more than ...
... against osteoporosis-related fractures, including spine and hip, - Reclast reduced spine ... placebo in study published in New England Journal of Medicine, - Unique once-yearly ... ... - Osteoporotic fractures affect one in two women over 50(1) and are ...
Cached Medicine Technology:Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity 2Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 2Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 3Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 4Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 5Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis 6
(Date:5/30/2015)... 30, 2015 AVT, the world leader ... is joining forces with leading proofing solutions provider Global ... worldwide printing market. , Under the agreement, ... engine for its offline inspection solutions, which are customized ... and its varying production workflow setups and printing applications. ...
(Date:5/30/2015)... Thousands of aesthetic industry professionals converged in ... the American Society for Aesthetic Plastic Surgery (ASAPS). ... the parent company of one of the fastest expanding ... growth, the one-of-a-kind device just sold its 2 millionth ... in the news for gaining the FDA’s stamp of ...
(Date:5/30/2015)... One of the pervasive problems plaguing ... options available. Often, the ruralness of a location can ... rural areas feeling the crunch of a strained healthcare ... of paying high premiums and copays, Online USA ... physicians via the power of the internet. , ...
(Date:5/30/2015)... May 30, 2015 ProIntro Magnify contains 30 ... and animations. Instantly add an elegant opening title to any ... a range of clean design layouts. ProIntro Magnify is created ... is extremely easy to use. Simply drag a preset into ... on-screen-controls and parameters in the Inspector window then watch as ...
(Date:5/30/2015)... Minnesota (PRWEB) May 30, 2015 ... acquired the Disability Income Associate (DIA) designation to ... The DIA designation is designed for insurance advisors, ... to further their knowledge and expertise associated with ... Earning the DIA designation is only the latest ...
Breaking Medicine News(10 mins):Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2Health News:Secura Consultants Expands Disability Insurance Expertise 2
... Studies conducted on the health effects of tea and alcohol ... while the latter can increase the chances of committing a ... effects of green tea, which is claimed to have numerous ... leukemia patients who drank the beverage had an improved clinical ...
... smokers who suffer from withdrawal symptoms at the Queensland's public ... inpatients of all the // public hospitals in the country ... cost, from 1 January 2006. ,As many ... year. ,Nicotine is capable of creating blood ...
... study has indicated that the use of short wide glasses ... to 30% more. This has been published in the ... small glasses than in the narrow tall glasses of the ... by professional bartenders. ,The study involved 198 ...
... Report of the rising rates of infection with C.difficile ... the mutation of the microorganism into a more virulent ... only manifest in individuals with resistance to antibiotics. ... among non-hospitalized patients has created much panic among the ...
... Merck & Co, known as MSD India, has entered into ... to conduct studies on the former's investigational cervical cancer drug, ... development in India. Under the agreement, clinical trials will be ... cervical cancer. ,The vaccine that has been developed by ...
... has revealed that there is no evidence which proves that ... billion by way of lost wages as a result of ... the British Medical Journal recommends moderation while drinking to prevent ... based product, tropisetron, fructose, tolfenamic acid, artichoke, prickly pear, and ...
Cached Medicine News:Health News:Rising Rates Of C.Difficile Infection Among Non-Hospitalized Patients 2Health News:Merck, ICMR to conduct joint trials on cervical cancer vaccine 2
... PelviSoft® Acellular Collagen BioMesh, provides ... tissue together with the porosity of ... for use in pelvic floor reconstruction. ... and cystocele prolapse, where plication alone ...
... Allograft meets the demanding ... floor reconstructive procedures, and ... suture pull-through, demonstrating long-term ... a structural support for ...
The High Pure Viral RNA Kit is intended for general laboratory use and is designed to purify viral RNA from serum or plasma. Viral RNA is used for RT-PCR analysis directly after elution in nuclease-f...
... The QIAamp Viral RNA Mini ... nucleic acids from cell-free fluid ... acids that can be isolated ... are not limited to, RNA ...
Medicine Products: